NCT00537368View on ClinicalTrials.gov

First Study of the Safety of CNTO 888 in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

March 31, 2010

Conditions
Cancer
Interventions
DRUG

CNTO 888

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY

NCT00537368 - First Study of the Safety of CNTO 888 in Patients With Solid Tumors | Biotech Hunter | Biotech Hunter